M&A Pfizer splits into three after failing to sell consumer unit Pfizer has decided to split into three after it failed to sell its consumer healthcare business a few months ago.
News Pfizer could fetch $15bn for consumer health business Pfizer is considering selling its consumer healthcare business in a deal that could be worth around $15 billion.
News Sanofi and BI finalise swap to create market leading consume... Sanofi and BI finalise CHC and animal health swap
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
